We speculate that Trio may have dual roles; it may play important roles in podocyte development but it may also regulate pathological Rac1 hyperactivation in the context of TGFβ1-mediated podocyte injury and glomerulosclerosis. The gene discussed is TRIO; the disease is glomerulosclerosis.